The Fastest Market Insights for India
Every filing from all 8,674 listed Indian companies, read and scored in about 10 seconds—and in your inbox while the market is still reading the headline.
- 8,674
- Companies covered
- ~10s
- To read and score a filing
- 100%
- Analysed, not sampled
- 197
- Industries
Coverage that doesn’t stop at the Nifty 50
Most tools cover the names everyone already watches. We read every filing from every listed company—across 197 industries, most of them without a single analyst assigned.
Companies in the covered universe
Of them small-cap — where filings go unread
Filed at least once in the last three days
Every filing is scored 1–10 for market impact and tagged against a fixed 29-category taxonomy—the same categories every time, so you can filter, route and backtest against them rather than re-reading free text.
This is what lands in your inbox
Six analyses the pipeline actually produced—unedited. Pick one to read it in full.
Pidilite Industries Reports Strong Q1 FY27 Results, Beats Consensus with 21.3% Revenue Growth and 30.3% PAT Surge
Pidilite Industries Limited delivered a robust financial performance for Q1 FY27, significantly surpassing analyst consensus estimates for both revenue and EPS. Consolidated Net Sales surged by 21.3% year-on-year to INR 4,541 crore, comfortably beating the consensus of INR 4,384.49 crore. Profit After Tax (PAT) witnessed an impressive 30.3% year-on-year growth, reaching INR 884 crore, which translates to an EPS of INR 8.69 per share, a substantial beat against the consensus of INR 6.21 per share. Despite a 90 basis points contraction in Gross Margin to 52.5% due to the inflationary impact of the West Asia crisis, the company demonstrated strong operational efficiency, improving consolidated EBITDA margin by 120 basis points to 26.3% through prudent cost management and proactive price increases. This strong performance, underpinned by resilient domestic demand and strategic investments in brand building, is expected to drive positive investor sentiment and potential re-rating of the stock.
- Sentiment
- positive
- Impact score
- 10 / 10
- Industry
- Specialty Chemicals
- Segment
- Large cap
- Filed
- 04 Aug 2026, 14:49 IST
Real analyses, generated automatically in about 10 seconds each. Every one of the ~1,600 filings we take in each day gets the same treatment.
From filing to scored analysis in seconds
No analyst in the loop. The same three steps run on every filing, all day.
- 01~1,600 filings a day
Watch
The exchange feed is polled continuously for every listed company — not a curated shortlist. Nothing is sampled and nothing is skipped.
- 02~10 seconds
Read
The attached document is opened and read in full — not skimmed from the headline. Where analyst estimates exist they're pulled in as context, so a result comes back as a beat or a miss against a number.
- 0329 fixed tags
Deliver
Scored 1–10, tagged, and sent to your inbox, the dashboard or the API — typically within minutes of the filing appearing.
Know what’s scheduled before it happens
We pull dates out of the filings themselves—board meetings, results, record dates, buybacks—and classify them into 19 event types. 1,984 are on the calendar right now, each with the reasoning that produced it.
The company announced a significant final and special dividend of ₹506 per share, representing a payout ratio over 100% of EPS, alongside strong FY25-26 financial results with increased revenue, profit, EPS, operating margin, RONW, and ROCE.
- Importance
- 10/10
- Direction
- positive
- Conviction
- 0.90
The company proposes to raise funds up to USD 65 million (approx. INR 5395 Cr), which is over 5 times its current market capitalization (INR 1041.92 Cr). The increase in FPI/NRI limits is an enabling resolution for this dilutive fundraising.
- Importance
- 10/10
- Direction
- negative
- Conviction
- 0.90
Analysts expect strong EPS growth (46.8% for the quarter) despite a recent slight miss.
- Importance
- 9/10
- Direction
- positive
- Conviction
- 0.75
Direction and conviction describe how the filing reads, not a price forecast. They are there to help you triage what to look at first—not to be traded on their own.
Built for anyone who has to read the filings
The same coverage underneath. What changes is how you consume it.
Cover the whole tape, not just your book
Every filing from every listed company, read and scored in seconds. Your analysts stop triaging the feed and start on the handful of things that actually matter.
The names nobody has time to read still get a full analysis — including the small- and mid-caps where filings go unexamined.
Qualified audit opinions, unprovisioned liabilities and going-concern language pulled out of the document itself, not the headline.
Scheduled results, board meetings and record dates extracted from filings, so positioning is never a surprise.